Cargando…

Toll-like receptor 9 agonist enhances anti-tumor immunity and inhibits tumor-associated immunosuppressive cells numbers in a mouse cervical cancer model following recombinant lipoprotein therapy

BACKGROUND: Although cytotoxic T lymphocytes (CTLs) play a major role in eradicating cancer cells during immunotherapy, the cancer-associated immunosuppressive microenvironment often limits the success of such therapies. Therefore, the simultaneous induction of cancer-specific CTLs and reversal of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Li-Sheng, Leng, Chih-Hsiang, Yeh, Yi-Chen, Wu, Chiao-Chieh, Chen, Hsin-Wei, Huang, Hai-Mei, Liu, Shih-Jen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4000133/
https://www.ncbi.nlm.nih.gov/pubmed/24642245
http://dx.doi.org/10.1186/1476-4598-13-60